---
title: "NexGel Raises $1.21 Million Via Convertible Notes and Warrants; $0.60 Conversion, $0.80 Exercise"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286613426.md"
description: "NexGel raised $1.21 million through a private placement of unsecured convertible notes and warrants, with a conversion price of $0.60 per share and a warrant exercise price of $0.80. The funds will support working capital, with a significant portion purchased by affiliates. NexGel also agreed to register the resale of underlying shares, enhancing investor liquidity."
datetime: "2026-05-15T20:43:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286613426.md)
  - [en](https://longbridge.com/en/news/286613426.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286613426.md)
---

# NexGel Raises $1.21 Million Via Convertible Notes and Warrants; $0.60 Conversion, $0.80 Exercise

NexGel secured $1.21 million in a private placement of unsecured convertible promissory notes and warrants with accredited investors, setting an initial note conversion price of $0.60 per share and a warrant exercise price of $0.80 for 1,008,334 shares, with warrants expiring five years from issuance. Proceeds will support working capital, and a significant portion was purchased by company affiliates. Concurrently, NexGel agreed to register the resale of the underlying shares, committing to file within 75 days and target effectiveness within 150 days, enhancing investor liquidity.

**Agreement 1: NexGel Raises $1.21 Million Via Convertible Notes and Warrants; $0.60 Conversion, $0.80 Exercise**

-   **Agreement type**: Securities Purchase Agreement for unsecured convertible notes and warrants (private placement)
-   **Counterparty**: Accredited Investors
-   **Signed / Effective**: May 11 2026 / same
-   **Duration / Termination**: Warrants: 5 years; Notes: N/A
-   **Reason**: Strengthen liquidity and fund working capital

**Agreement 2: NexGel Agrees to Register Resale of Note and Warrant Shares Under New Registration Rights Deal**

-   **Agreement type**: Registration Rights Agreement for resale of note and warrant shares
-   **Counterparty**: Accredited Investors
-   **Signed / Effective**: May 11 2026 / same
-   **Duration / Termination**: N/A
-   **Reason**: Provide resale liquidity to investors

Original SEC Filing: NEXGEL, INC. \[ NXGL \] - 8-K - May. 15, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [NXGL.US](https://longbridge.com/en/quote/NXGL.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [NXGLW.US](https://longbridge.com/en/quote/NXGLW.US.md)

## Related News & Research

- [NXGL: Q2 revenue reached $3.69M with a $2.87M net loss; integration and expansion efforts continue](https://longbridge.com/en/news/296106108.md)
- [Nexgel’s Celularity Deal: Execution, Integration, and Profitability Risks from $13.3 Million Biomaterials Acquisition](https://longbridge.com/en/news/296183101.md)
- [NXGL: Q2 2026 revenue up 27.8% to $3.7M, but net loss widened and going concern risks persist](https://longbridge.com/en/news/296088966.md)
- [NexGel shareholders constrain structural changes at annual meeting](https://longbridge.com/en/news/295023136.md)
- [Nexgel CEO Adam R. Levy sells 11,000 common shares worth $6,534.1](https://longbridge.com/en/news/290619350.md)